Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US

Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US

South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...

Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum

Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum

South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...

Korea Hanmi to launch blockbuster hypertension drug in China

Korea Hanmi to launch blockbuster hypertension drug in China

South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...

President Lee meets Hyundai, LG chiefs, promotes ‘one team’ approach Hanwan Ocean wins $1.4 bn order to build 7 LNG dual-fuel ships K-content reign continues as Squid Game returns in force South Korea’s EV exports rebound in June after 16-month decline Yes, it’s K-beauty: Strong buying appetite for makeup brands even before they're up for sale
banner